Tuesday, December 25, 2012 12:41:00 PM
From 10 yrs ago to give you a sense of what he brings to the table:
http://www.twst.com/interview/8279
Again, I believe he will help AMBS strike an in licensing deal and also get help them get substantial funding. I believe AMBS should be worth at least $75 mill right now (about 4 to 5 times current value). I'm basing this on relative valuation for GDNF with a substantial discount and on patent protection...remember a partner from Hermo Pharma (VC backed and MJFF funded company that challenged the company's MANF patents and lost) was quoted as saying that the company's MANF patents "cause an undue burden" on anyone trying to test MANF or anything with a 90% homology (ie similarity) to it.
http://m.seekingalpha.com/instablog/167303-jonathan-verenger/1348791-exciting-field-in-cure-for-parkinson-s
Don't listen to college kids like solantey with $3000 to their name warning of impending doom because they're naive enough to think they can manipulate a stock. They sold and want back in at lower prices...they see the writing on the wall. They made a mistake. Those of us that have been patient enough to hold and continue to hold will reap massive benefits. It won't be easy to hold with huge gains but the valuation is way too low.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM